מיפג'ין
a. lapidot pharmaceuticals, ltd - mifepristone - טבליה - mifepristone 200 mg - mifepristone - mifepristone - medical alternative to uterine suction for termination of intra-utrerine pregnancy: - up to and no later than 49 days of amenorrhea (seven weeks) - in sequential use with a prostaglandin analogue misoprostol 400 mcg per os administered 36 to 48 hours after mifegyne intake. under these conditions the association of mifepristone and prostaglandins leads to a success rate of about 95 per cent of the cases. preparation for the action of prostaglandin analogues in the termination of pregnancy for medical reason (beyond the first trimester). softening and dilatation of the cervix uteri prior to surgical termination of pregnancy during the first trimester.
זפוסיה 0.23 מג
bristol, myers squibb (israel) limited, israel - ozanimod as hydrochloride - קפסולות - ozanimod as hydrochloride 0.23 mg - ozanimod
זפוסיה 0.46 מג
bristol, myers squibb (israel) limited, israel - ozanimod as hydrochloride - קפסולות - ozanimod as hydrochloride 0.46 mg - ozanimod
זפוסיה 0.92 מג
bristol, myers squibb (israel) limited, israel - ozanimod as hydrochloride - קפסולות - ozanimod as hydrochloride 0.92 mg - ozanimod
רבלוזיל 25 מג
bristol, myers squibb (israel) limited, israel - luspatercept - אבקה להכנת תמיסה לזריקה - luspatercept 25 mg - luspatercept
רבלוזיל 75 מג
bristol, myers squibb (israel) limited, israel - luspatercept - אבקה להכנת תמיסה לזריקה - luspatercept 75 mg - luspatercept
אונורג 200 מג
bristol, myers squibb (israel) limited, israel - azacitidine - טבליות מצופות פילם - azacitidine 200 mg - azacitidine
אונורג 300 מג
bristol, myers squibb (israel) limited, israel - azacitidine - טבליות מצופות פילם - azacitidine 300 mg - azacitidine
קסלג'אנז 5 מג
pfizer pharmaceuticals israel ltd - tofacitinib - טבליה - tofacitinib 5 mg - tofacitinib
קסלג'אנז 5 מג
pfizer pharmaceuticals israel ltd - tofacitinib - טבליה - tofacitinib 5 mg - tofacitinib